BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24783207)

  • 1. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.
    Distler M; Aust D; Weitz J; Pilarsky C; Grützmann R
    Biomed Res Int; 2014; 2014():474905. PubMed ID: 24783207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precancerous lesions of the pancreas.
    Zamboni G; Hirabayashi K; Castelli P; Lennon AM
    Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):299-322. PubMed ID: 23809247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.
    Basturk O; Hong SM; Wood LD; Adsay NV; Albores-Saavedra J; Biankin AV; Brosens LA; Fukushima N; Goggins M; Hruban RH; Kato Y; Klimstra DS; Klöppel G; Krasinskas A; Longnecker DS; Matthaei H; Offerhaus GJ; Shimizu M; Takaori K; Terris B; Yachida S; Esposito I; Furukawa T;
    Am J Surg Pathol; 2015 Dec; 39(12):1730-41. PubMed ID: 26559377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].
    Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F
    Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilemma in classifications of possible precursors of pancreatic cancer involving the main pancreatic duct: PanIN or IPMN?
    Takaori K
    J Gastroenterol; 2003; 38(3):311-3. PubMed ID: 12693387
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathology of Pancreatic Cancer Precursor Lesions.
    Noë M; Brosens LA
    Surg Pathol Clin; 2016 Dec; 9(4):561-580. PubMed ID: 27926360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precursor lesions in pancreatic cancer: morphological and molecular pathology.
    Scarlett CJ; Salisbury EL; Biankin AV; Kench J
    Pathology; 2011 Apr; 43(3):183-200. PubMed ID: 21436628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precursors to invasive pancreatic cancer.
    Maitra A; Fukushima N; Takaori K; Hruban RH
    Adv Anat Pathol; 2005 Mar; 12(2):81-91. PubMed ID: 15731576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Precursors of Pancreatic cancer: Intraepithelial Neoplasia (PanIN) and Intraductal Papillary Mucinous Neoplasms (IPMN)].
    Ledniczky G; Bognár G; Bereczky B; Barabás L; Ondrejka P
    Magy Seb; 2009 Feb; 62(1):22-6. PubMed ID: 19218165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular signatures of pancreatic cancer.
    Hong SM; Park JY; Hruban RH; Goggins M
    Arch Pathol Lab Med; 2011 Jun; 135(6):716-27. PubMed ID: 21631264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
    Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
    Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current understanding of precursors to pancreatic cancer.
    Takaori K
    J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic aspects of intraductal papillary-mucinous neoplasm and pancreatic intraepithelial neoplasia--their associations with carcinogenesis.
    Furukawa T
    Nihon Shokakibyo Gakkai Zasshi; 2007 Sep; 104(9):1329-37. PubMed ID: 17827903
    [No Abstract]   [Full Text] [Related]  

  • 15. Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas.
    Pittman ME; Rao R; Hruban RH
    Arch Pathol Lab Med; 2017 Dec; 141(12):1606-1614. PubMed ID: 29189063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cells of origin of pancreatic neoplasms.
    Yamaguchi J; Yokoyama Y; Kokuryo T; Ebata T; Nagino M
    Surg Today; 2018 Jan; 48(1):9-17. PubMed ID: 28260136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathology and classification of intraductal papillary mucinous neoplasms of the pancreas].
    Schlitter AM; Esposito I
    Chirurg; 2012 Feb; 83(2):110-5. PubMed ID: 22271052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
    Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M
    Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New insights into the origin of pancreatic cancer. Role of atypical flat lesions in pancreatic carcinogenesis].
    Esposito I; Konukiewitz B; Schlitter AM; Klöppel G
    Pathologe; 2012 Nov; 33 Suppl 2():189-93. PubMed ID: 23011021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic intraepithelial neoplasia.
    Takaori K; Hruban RH; Maitra A; Tanigawa N
    Pancreas; 2004 Apr; 28(3):257-62. PubMed ID: 15084967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.